Home › Stargardt Disease › Florida
Stargardt Disease clinical trials in Florida
8 studies for Stargardt Disease are looking for participants at sites in Florida.
Cities in Florida
Study of ALK-001 on the Progression of Stargardt Disease
- Vitreo Retinal Associates, Gainesville
RecruitingPhase 3
Ages 8 to 45 · All sexes · Updated Sep 18, 2026 · NCT07419334A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
- University of Florida Health - UF Health Jacksonville, Jacksonville
- University of Miami Health System - Bascom Palmer Eye Institute, Miami
RecruitingObservational study
Ages 6 and older · All sexes · Updated Aug 25, 2026 · NCT07425574A Study of AAVB-039 in Participants With Stargardt Disease (STGD1)
- University of Florida Health Science Center, Jacksonville
RecruitingPhase 1/2
Ages 8 to 55 · All sexes · Updated Jul 30, 2026 · NCT07161544Stem Cell Ophthalmology Treatment Study II
- MD Stem Cells, Coral Springs
Recruiting
Ages 18 and older · All sexes · Updated Jun 29, 2026 · NCT03011541Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)
- Vitreo Retinal Associates, Gainesville
RecruitingObservational study
Ages 5 and older · All sexes · Updated Mar 11, 2026 · NCT06445322Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR)
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
RecruitingPhase 1/2
Ages 12 and older · All sexes · Updated Dec 2, 2025 · NCT06467344An Observational Study in Subjects to Follow the Progression of Stargardt Disease Type 1 (STGD1) Caused by Bi-Allelic Autosomal Recessive Mutations in the ABCA4 Gene
- Vitreo Retinal Associates, Gainesville
- Bascom Palmer Eye Institute, Miami
RecruitingObservational study
Ages 12 to 65 · All sexes · Updated Sep 19, 2025 · NCT06435000A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)
- Bascom Palmer Eye Institute, Miami
RecruitingPhase 1/2
Ages 12 to 65 · All sexes · Updated Apr 29, 2025 · NCT06942572From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.